You have 9 free searches left this month | for more free features.

VHL Gene

Showing 1 - 25 of 5,892

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

VHL - Von Hippel-Lindau Syndrome, VHL Gene Mutation, VHL Syndrome Trial in Worldwide (Belzutifan)

Active, not recruiting
  • VHL - Von Hippel-Lindau Syndrome
  • +5 more
  • Bethesda, Maryland
  • +10 more
Aug 16, 2022

Polycythemia; Familial, Erythrocytosis; Familial, VHL Gene Mutation Trial (Digoxin)

Not yet recruiting
  • Polycythemia; Familial
  • +5 more
  • (no location specified)
Feb 2, 2022

Frequency, Clinical Phenotype and Genetic Analysis of Heritable

Not yet recruiting
  • Renal Tumor Histology
  • +13 more
  • Gene test
  • Shanghai, Shanghai, China
    Ethics Committee of Shanghai Renji Hospital
Sep 6, 2022

Von Hippel-Lindau Disease, Hereditary Leiomyomatosis and Renal Cell Cancer, Birt-Hogg-Dube Syndrome Trial in Boston

Recruiting
  • Von Hippel-Lindau Disease
  • +3 more
    • Boston, Massachusetts
      VHL Alliance
    Oct 4, 2021

    Clear Cell Kidney Cancer, Kidney Cancer, Kidney Cancer With PBRM1/BAP1/VHL/SETD2 Mutations Trial (Axitinib 5 MG)

    Available
    • Clear Cell Kidney Cancer
    • +2 more
    • Axitinib 5 MG
    • (no location specified)
    Jul 3, 2023

    Hemangioblastoma of CNS, Von Hippel-Lindau Disease Trial in Le Kremlin Bicêtre (Propranolol, follow-up)

    Not yet recruiting
    • Hemangioblastoma of CNS
    • Von Hippel-Lindau Disease
    • Le Kremlin Bicêtre, France
      AP-HP, Bicêtre Hospital
    Jun 14, 2022

    Von Hippel-Lindau: Clinical Manifestations, Diagnosis,

    Recruiting
    • Kidney Cancer
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 25, 2023

      Hereditary Leiomyomatosis Renal Cell Cancer - Study of Genetic

      Recruiting
      • Renal Tumor Histology
      • +2 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Dec 28, 2022

        Von Hippel-Lindau Disease Trial (68Ga-NY104 PET/CT Contrast-enhanced MRI of the brain and contrast-enhanced CT of abdomen and

        Not yet recruiting
        • Von Hippel-Lindau Disease
        • 68Ga-NY104 PET/CT Contrast-enhanced MRI of the brain and contrast-enhanced CT of abdomen and pelvis) 68Ga-NODAGA-LM3 PET/CT (exploratory)
        • (no location specified)
        Mar 30, 2023

        Patients With Von Hippel Lindau Disease

        Not yet recruiting
        • Von Hippel Lindau Disease
          • Houston, Texas
            M D Anderson Cancer Center
          Jul 18, 2023

          Early Development of Endometrial Carcinoma

          Recruiting
          • Cancer of Endometrium
            • Ferrara, Italy
              Section of Obstetrics and Gynecology, Department of Morphology,
            Apr 4, 2022

            Von Hippel-Lindau Disease Genetic Epidemiology Study

            Terminated
            • Von Hippel Lindau Disease
            • Kidney Neoplasms
              • Bethesda, Maryland
                National Institutes of Health Clinical Center, 9000 Rockville Pi
              Jan 9, 2020

              Germline Mutations Associated With Hereditary Pancreatic Cancer

              Recruiting
              • Pancreatic Cancer
              • Pancreatic Adenocarcinoma
              • Invitae Multi-Cancer Panel ®
              • Mexico City, Mexico
                Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubi
              Mar 22, 2022

              VHL Pancreatic Neuroendocrine Tumors, Von Hippel-Lindau Disease, Neuroendocrine Tumors Trial run by the National Cancer

              Recruiting
              • VHL Pancreatic Neuroendocrine Tumors
              • +2 more
              • 68-Gallium DOTATATE
              • Bethesda, Maryland
                National Institutes of Health Clinical Center
              Jan 26, 2023

              Von Hippel-Lindau Disease, Genetic Disorder Trial in Boston (3RP-VHL)

              Not yet recruiting
              • Von Hippel-Lindau Disease
              • Genetic Disorder
              • 3RP-VHL
              • Boston, Massachusetts
                Massachusetts General Hospital Cancer Center
              Feb 10, 2023

              Pheochromocytoma/Paraganglioma, Pancreatic Neuroendocrine Tumor, Von Hippel-Lindau Disease Trial in Worldwide (Belzutifan)

              Recruiting
              • Pheochromocytoma/Paraganglioma
              • +2 more
              • Los Angeles, California
              • +58 more
              Jan 27, 2023

              Von Hippel-Lindau Syndrome Trial run by the NEI (Ranibizumab, E10030)

              Completed
              • Von Hippel-Lindau Syndrome
              • Bethesda, Maryland
                National Institutes of Health Clinical Center
              Oct 21, 2021

              Leber Congenital Amaurosis Trial in Shanghai (HG004)

              Recruiting
              • Leber Congenital Amaurosis
              • HG004
              • Shanghai, Shanghai, China
                Xinhua Hospital affiliated with Shanghai Jiao Tong UniversitySch
              Oct 12, 2023

              Liver Biopsy Following Gene Therapy For Hemophilia

              Not yet recruiting
              • Hemophilia A
              • Hemophilia B
              • Liver Biopsy
              • Memphis, Tennessee
                St. Jude Children's Research Hospital
              Jun 27, 2023

              Leber Congenital Amaurosis Trial in Shanghai (HG004)

              Recruiting
              • Leber Congenital Amaurosis
              • HG004
              • Shanghai, Shanghai, China
                Xinhua Hospital affiliated with Shanghai Jiao Tong University Sc
              Sep 26, 2023

              Study of Retinal Dystrophies Associated With Rare

              Active, not recruiting
              • Inherited Retinal Degeneration
              • Retinitis Pigmentosa
                • Phoenix, Arizona
                • +23 more
                Jan 24, 2023

                Heart Failure, Diastolic, Heart Failure With Preserved Ejection Fraction Trial in Durham, Dallas (AAV1/SERCA2a)

                Recruiting
                • Heart Failure, Diastolic
                • Heart Failure With Preserved Ejection Fraction
                • AAV1/SERCA2a
                • Durham, North Carolina
                • +1 more
                Sep 23, 2023

                Solid Tumors Trial (afatinib)

                No longer available
                • Solid Tumors
                • (no location specified)
                Nov 7, 2022

                Renal Cell Carcinoma Trial in Philadelphia (drug, genetic, other, procedure)

                Terminated
                • Renal Cell Carcinoma
                • Brivanib alaninate
                • +5 more
                • Philadelphia, Pennsylvania
                  Abramson Cancer Center of the University of Pennsylvania
                Mar 18, 2021

                Leber Congenital Amaurosis Trial (HG004)

                Not yet recruiting
                • Leber Congenital Amaurosis
                • (no location specified)
                Jun 13, 2023